Top 50 Biotechnology Startup Investors in Italy (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
14 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $494k–$17M |
|
Sofinnova Partners
VC Fund
|
12 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$120M |
|
Italian Angels for Growth
VC Fund
|
9 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Indaco Venture Partners
VC Fund
|
9 | Italy, Switzerland, United States | Series A, Series B, Series C | Biotechnology, Health Care, Life Science | $1.5M–$74M |
|
Vertis
VC Fund
|
7 | Italy, United States, United Kingdom | Seed, Series A | Software, Computer, E-Commerce | $823k–$10M |
|
Principia SGR
VC Fund
|
6 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
LIFTT
VC Fund
|
6 | Italy, United Kingdom, France | Seed, Series A | Software, Biotechnology, Manufacturing | $329k–$21M |
|
Claris Ventures
VC Fund
|
6 | Italy, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Life Science | $2.2M–$25M |
|
UniCredit
VC Fund
|
5 | Italy, Germany, Spain | Debt Financing, Post-IPO Debt | Manufacturing, Renewable Energy, Energy | $521k–$1.4B |
|
Innogest Capital
VC Fund
|
5 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
A11 Venture
VC Fund
|
4 | Italy, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical Device, E-Commerce | $384k–$1.4M |
|
Green Arrow Capital
VC Fund
|
4 | Italy, United Kingdom | Seed, Series A | Health Care, Biotechnology, Manufacturing | $1.5M–$2.2M |
|
Progress Tech Transfer Fund
VC Fund
|
3 | Italy, Ireland, United Kingdom | Series A, Seed | Water, Biotechnology, Manufacturing | $176k–$15M |
|
Invitalia Ventures
VC Fund
|
3 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, Internet | $658k–$6.2M |
|
INGENIUM Emilia Romagna
VC Fund
|
3 | Italy | Seed, Angel | Medical, Health Care, Privacy | $2.1M–$2.2M |
|
EUREKA! Venture SGR
VC Fund
|
3 | Italy | Seed, Pre-Seed | Nanotechnology, Manufacturing, Medical Device | $384k–$4.1M |
|
Fondazione Cariverona
VC Fund
|
3 | Italy, Switzerland, The Netherlands | Pre-Seed, Seed | Biotechnology, Cosmetics, GreenTech | $197k–$197k |
|
Panakes Partners
VC Fund
|
3 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $4.4M–$110M |
|
Club degli Investitori
VC Fund
|
3 | Italy, Switzerland, United Kingdom | Seed, Series A | Health Care, E-Commerce, Information Technology | $197k–$19M |
|
Atlante Ventures
VC Fund
|
3 | Italy, United States, Israel | Seed, Series A | Software, Biotechnology, Hardware | $150k–$3.5M |
|
3B Future Health Fund
VC Fund
|
2 | United States, Italy, United Kingdom | Series B, Series A | Biotechnology, Therapeutics, Medical | $2.7M–$43M |
|
Lazio Innova
VC Fund
|
2 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Software, Health Care, Artificial Intelligence | $27k–$1.3M |
|
ENEA Tech e Biomedical
VC Fund
|
2 | Italy, Finland | Venture - Series Unknown, Series A, Grant | Health Care, Biotechnology, Medical Device | $530k–$21M |
|
Stefano Bernardi
Angel
|
2 | Italy, United Kingdom, France | Seed, Pre-Seed | Software, Biotechnology, Artificial Intelligence | $100k–$45M |
|
byFounders
VC Fund
|
2 | Denmark, United States, Sweden | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Health Care | $800k–$65M |
|
Barbara Castellano
Angel
|
2 | Italy | Pre-Seed | Health Care, Biotechnology, Medical Device | |
|
XGEN Venture
VC Fund
|
2 | Italy, Sweden, Germany | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $4.6M–$141M |
|
European Circular Bioeconomy Fund
VC Fund
|
2 | Germany, France, The Netherlands | Series A, Series B, Venture - Series Unknown | Biotechnology, AgTech, Agriculture | $4.4M–$43M |
|
Banco BPM
VC Fund
|
2 | Italy, United States, Spain | Debt Financing, Post-IPO Debt, Pre-Seed | Manufacturing, Renewable Energy, Health Care | $549k–$878M |
|
StartUp Health
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Italian Angels for Biotech
VC Fund
|
2 | Italy | Seed | Health Care, Biotechnology, Pharmaceutical | $549k–$2M |
|
3LB Seed Capital Srl
VC Fund
|
2 | Italy, United States, United Kingdom | Seed, Pre-Seed, Series A | E-Commerce, Software, Information Technology | $71k–$2.5M |
|
European Investment Bank
VC Fund
|
2 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$658M |
|
Kering Ventures
VC Fund
|
2 | Italy | Series A | Biotechnology, Interior Design | $12M–$12M |
|
The Techshop
VC Fund
|
2 | Italy, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, FinTech | $658k–$120M |
|
Enrico Pandian
Angel
|
2 | Italy, United States | Seed, Pre-Seed, Angel | E-Commerce, SaaS, FinTech | $878k–$3.8M |
|
Scientifica Venture Capital
VC Fund
|
2 | Italy, Sweden, Finland | Seed, Pre-Seed | Biotechnology, Health Care, Manufacturing | $209k–$2.9M |
|
Longwood Fund
VC Fund
|
1 | United States, United Kingdom, Italy | Series A, Series B, Series C | Biotechnology, Therapeutics, Health Care | |
|
DSM-Firmenich Venturing
VC Fund
|
1 | United States | Series A | Health Care, Biotechnology, Food and Beverage | |
|
Planet A Ventures
VC Fund
|
1 | Germany, United Kingdom, Italy | Seed, Series A | Software, Manufacturing, Renewable Energy | |
|
Angels 4 Impact
VC Fund
|
1 | Italy | Seed | Consulting, Biotechnology, Manufacturing | |
|
Lombardstreet Ventures
VC Fund
|
1 | United States, United Kingdom, Italy | Seed, Pre-Seed, Series A | Software, Information Technology, SaaS | |
|
Launch Tennessee
VC Fund
|
1 | United States, China, Italy | Grant, Seed, Series A | Software, Health Care, Medical | |
|
Andrea Dusi
Angel
|
1 | Italy, United States, United Kingdom | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Information Technology | |
|
Schia Ventures
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
Spindial Group
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
MPM Capital
VC Fund
|
1 | United States, United Kingdom, Canada | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | |
|
RECOMEC
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
Pi Campus
VC Fund
|
1 | Italy, United States, United Kingdom | Seed, Pre-Seed | Software, Mobile, Biotechnology | |
|
Crédit Agricole Italia
VC Fund
|
1 | Italy | Debt Financing, Seed | Financial Services, Finance, Water | |
| Access all 198 investors in Italy Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 245
- Round size: Seed $494k–$8.2M; Series A $3.3M–$17M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Mopso — Discover Mopso's anti money laundering detection system. Visit our website and try a 30 minutes free demo with one of our experts.
- CamGraPhIC — Our platform supports the ever-increasing data traffic demand with high-performing and low-power consumption electro-optical engines.
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 309
- Round size: Series A $6M–$67M; Series B $10M–$120M; Series C $12M–$100M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
- l'école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
- EndoRon Medical — Endoron Medical develops an endovascular suture, like a device for the effective treatment of an abdominal aortic aneurysm.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 103
- Round size: Seed $329k–$5.9M; Angel $219k–$1.2M; Series A $2.7M–$14M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
- Fitprime — Il Partner unico per il Wellbeing Aziendale
- Alomana —
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Series C
- Geography: Italy, Switzerland, United States
Investor stats
- Total investments: 42
- Round size: Series A $1.5M–$31M; Series B $8.8M–$52M; Series C $16M–$74M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- CamGraPhIC — Our platform supports the ever-increasing data traffic demand with high-performing and low-power consumption electro-optical engines.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more...Investment focus
- Industry: Software, Computer, E-Commerce
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 65
- Round size: Seed $823k–$3.6M; Series A $1.5M–$10M
- Lead/follow: 58% lead, 42% follow
- Last fund: Likely still investing — raised $35M in 2021
Portfolio highlights
- Quido AI — Quido is the co-pilot for investment professionals. Quido allows private capital professionals to streamline data retrieval and data analysis and dramatically increase their efficiency.
- Focoos AI — Focoos reshapes computer vision with ultra-efficient models that drive down costs, automate hardware integration, and ensure peak performance on any device, while promoting sustainability.
- TimeFlow — TimeFlow is a software that acts as a B2B marketplace dedicated to the technical and managerial consulting sector.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 71
- Round size: Seed $329k–$4.7M; Series A $2.7M–$21M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
- Maieutical Labs — I Maieutical Labs sono un insieme di piattaforme ispirate al Mastery Learning, immersive e mobile-oriented, dedicate allo studio nella scuola secondaria
- RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Series A, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 15
- Round size: Seed $2.2M–$11M; Series A $6.1M–$25M; Series B $7.9M–$20M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- Haptena Therapeutics — Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.
- Resalis Therapeutics — Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.
Show more...Investment focus
- Industry: Manufacturing, Renewable Energy, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: Italy, Germany, Spain
Investor stats
- Total investments: 127
- Round size: Post-IPO Debt $40M–$1.4B; Debt Financing $521k–$899M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Banxware — Banxware provides the technology and the funds for business financing of any kind: fully embedded in your platform or as an affiliate solution - all managed by Banxware
- FITT — FITT specializes in thermoplastic fluid transfer and management solutions.
- EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Prestiamoci — Prestiamoci is the first community of loans between individuals born in Italy, allowing you to make profitable investment and to obtain loans with installments transparent.With Prestiamoci the providers invest and get Claimants, returning to its original role of the bank safe. Loans shall be paid by people to trustworthy people who want toachieve their life projects, grow their professional activity, better manage expenses and major purchases
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States
Investor stats
- Total investments: 13
- Round size: Seed $384k–$1.4M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
- Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
- Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 9
- Round size: Series A $1.5M–$2.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
- Maticmind S.p.A — Maticmind S.p.A is a company that provides ICT and system integration solutions to telecommunications operators.
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Investment fund specialized in sustainable technologies from universities and public research organizations, start-ups, spin-offs, and entrepreneurs.
Show more...Investment focus
- Industry: Water, Biotechnology, Manufacturing
- Stage:Series A, Seed
- Geography: Italy, Ireland, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $176k–$1.6M; Series A $9.9M–$15M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- SQIM — SQIM is a biotechnological based agency.
- Naturbeads — Naturbeads creates biodegradable, sustainable and cost competitive cellulose microbeads to replace currently used microplastics.
- Valuematic — Valuematic realizza soluzioni per il trattamento e gestione dei dati favorendo il miglioramento nei processi organizzativi e informativi di aziende ed enti.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, Internet
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Industry: Medical, Health Care, Privacy
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2.1M–$2.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more...Investment focus
- Industry: Nanotechnology, Manufacturing, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 32
- Round size: Seed $384k–$4.1M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- FLEEPtech — FLEEP Technologies designs and develops printed electronics solutions for the biomedical and smart packaging sectors. The company, spin-off of Istituto Italiano di Tecnologia, was founded in May 2019.FLEEPtech developed a proprietary process for the fabrication of polymer-based integrated circuits based on Organic Thin-Film Transistors, creatingthe intelligent core for electronics systems that are mechanically flexible, printed like magazines and recyclable. FLEEPtech is the missing link in the printed electronics industry between a great number of flexible and printed products (i.e. sensors, actuators and energy supplies) that find little space in being integrated with standard non-flexible electronics. For such reasons, the company's mission revolves around the realization of a general purpose platform for the manufacturing of fully-printed integrated systems, composed by printed sensors, printed actuators, printed energy supplies and harvesters and, of course, printed integrated circuits.
- Novac — Progettiamo supercondensatori da affiancare alle batterie, per incrementare performance ed efficienza dei veicoli elettrici.
- INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
Fondazione Cariverona. Da oltre 25 anni per lo sviluppo civile, culturale ed economico di Verona, Vicenza, Belluno, Ancona e Mantova.
Show more...Investment focus
- Industry: Biotechnology, Cosmetics, GreenTech
- Stage:Pre-Seed, Seed
- Geography: Italy, Switzerland, The Netherlands
Investor stats
- Total investments: 8
- Round size: Pre-Seed $197k–$197k
- Lead/follow: 88% lead, 12% follow
Portfolio highlights
- Noiet — Noiet is a biotechnology firm whose mission is to develop clean, natural, and fermented proteins that serve as multifunctional alternatives.
- Peelpack — Peelpack is a packaging company that specializes in biodegradable and compostable biopolymer punnets, aiming to replace plastic packaging.
- Alma Serum — Alma Serum is a cosmetic and biotech company that turns dairy industry into advanced cosmetic and biomedical materials.
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 42
- Round size: Series A $4.4M–$79M; Series B $9.9M–$60M; Series C $18M–$110M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
- CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more...Investment focus
- Industry: Health Care, E-Commerce, Information Technology
- Stage:Seed, Series A
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 96
- Round size: Seed $197k–$7.6M; Series A $889k–$19M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Largix — Largix is the first company to develop and commercially produce 3D Robotic Printers for real production processes. We have invented the "Cold 3D Printing®" technology that makes 3DP possible for real industrial production. Largix uses the most common thermoplastic polymers: Polypropylene and Polyethylene, polymers that nobody else iscapable of printing.
- Spacest.com By Roomless — Rent directly online with Roomless, the safe and simple platform for those looking for a house for rent.
- Approxima — Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.
Show more...Investment focus
- Industry: Software, Biotechnology, Hardware
- Stage:Seed, Series A
- Geography: Italy, United States, Israel
Investor stats
- Total investments: 46
- Round size: Seed $150k–$3.5M; Series A $1.5M–$3.3M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2007
Portfolio highlights
- ADmantX — A NEW ERA OF AUDIENCE TARGETINGADmantX is a contextual analysis and data provider that brings audience targeting to a new level. Awarded patent for semantic advertising technology, the company offers a cookie-less solution that allows publishers, ad networks and exchanges, brand managers and agencies to develop more effective online adcampaigns leveraging semantic understanding, natural language processing and sentiment analysis. Founded in Italy as a spin-off of the leading semantic company Expert System, ADmantX is active in Europe and US. Worldwide customers include NBCUniversal, Integral Ad Science, Networked Insights, Banzai, Cadreon, Amnet, Sojern, Media IQ and ADmantX solutions are integrated in key DSP players such as Turn, Adform and AppNexus.
- YOGITECH — Notizie e approfondimenti di Tecnologia
- Expert.ai — Expert.ai is the premier artificial intelligence platform for language understanding.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series B, Series A
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 33
- Round size: Series A $2.7M–$43M; Series B $7.9M–$40M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- Roca Therapeutics — First-in-Class Drugs against ocular diseases driven by hyper-vascularization and immuno-suppressive inflammation.A united team creating an innovative therapy to give a new vision to patients.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 21
- Round size: Seed $186k–$1.3M; Grant $27k–$33k; Pre-Seed $53k–$549k
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- HEU — HEU is a legaltech company that automates and manages legal documents and allows users to edit and share them.
- Joinrs — Cut the noise. Joinrs uses AI to find the jobs that actually match your skills, experience and preferences. Over 2 million job seekers trust Joinrs.
- Ticketoo — Compra e vendi biglietti in modo etico su Ticketoo. La piattaforma sicura per transazioni fan-to-fan. Trova i migliori eventi e assicurati il biglietto per i tuoi spettacoli preferiti.
ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Series A, Grant
- Geography: Italy, Finland
Investor stats
- Total investments: 13
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 17
- Round size: Seed $100k–$45M; Pre-Seed $1.4M–$2.2M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- iubenda — Make your sites & apps legally compliant across multiple languages and legislations (including the GDPR) with our lawyer-crafted, self-updating solutions.
- Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
- Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
byFounders is the community-powered early-stage venture fund investing in globally ambitious teams connected to the Nordic and Baltic countries. With its unique Collective of founders and operators, byFounders offers its portfolio operational expertise and a global network. Believing in the power of tech to shape our future, byFounders takes an impact-aware approach to investing and working with the broader startup ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Denmark, United States, Sweden
Investor stats
- Total investments: 104
- Round size: Seed $1.5M–$8M; Pre-Seed $800k–$4.2M; Series A $6.1M–$65M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — raised $117M in 2021
Portfolio highlights
- Flare — Flare builds infrastructure for a more internet by connecting real-world data with machine learning in a verifiable way.This combines human intelligence with advanced AI to improve the clarity and reliability of information.Its goal is to create a shared, high-quality knowledge foundation that helps people navigate information with confidence.
- Verda (formerly DataCrunch) — DataCrunch is a cloud service provider which facilitates utilization and integration of state of the art AI/ML models
- Spiral Hydrogen — Spiral Hydrogen's mission is to lower the price of green hydrogen below that of fossil hydrogen, so opening up an industry for decarbonization and making hydrogen transportation and heating commercially viable.
Laura Iris Ferro
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
- CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
XGEN Venture is an Italian alternative investment fund manager (Società di Gestione del Risparmio, or SGR) with over 15 years of experience in the startup process and the development of innovative solutions for high unmet medical needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: Italy, Sweden, Germany
Investor stats
- Total investments: 8
- Round size: Series A $33M–$98M; Series B $4.6M–$141M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- NanoPhoria — NanoPhoria is a biotechnology company focused on the development of innovative cardiovascular treatments. It specializes in a non-viral, nano-in-micro delivery system for biologics, designed to target the heart directly. This preclinical stage company is exploring the potential of inhalable therapies, utilizing tissue-directed delivery methods fortherapeutic peptides and RNAs. NanoPhoria's approach aims to revolutionize the treatment of cardiovascular diseases by offering a versatile, non-viral drug delivery platform, formulated for both inhalation and other administration routes. With a dedicated team, NanoPhoria is committed to advancing cardiovascular health through groundbreaking research and development.
- TES Pharma — TES Pharma is a research-based biopharmaceutical company focusses on delivering first in class preclinical candidates that unlock the potential of novel therapeutic targets and mechanisms.
- EpilepsyGTx — EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy (FRE).
The specialist VC for a regenerative economy
Show more...Investment focus
- Industry: Biotechnology, AgTech, Agriculture
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Germany, France, The Netherlands
Investor stats
- Total investments: 24
- Round size: Series A $4.7M–$30M; Series B $4.4M–$43M; Venture - Series Unknown $8.7M–$20M
- Lead/follow: 71% lead, 29% follow
- Last fund: Likely still investing — raised $351M in 2022
Portfolio highlights
- AmphiStar — We are developing a proprietary technology platform for the ecological production of biosurfactants, that are clean, safe, sustainable and biodegradable
- Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
- Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
Scopri i servizi bancari e finanziari di Banco BPM: conti, mutui, carte, prestiti, assicurazioni, trading e tanto altro. Per privati e imprese.
Show more...Investment focus
- Industry: Manufacturing, Renewable Energy, Health Care
- Stage:Debt Financing, Post-IPO Debt, Pre-Seed
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 47
- Round size: Post-IPO Debt $8.8M–$878M; Debt Financing $549k–$692M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Corali — Corali is a manufacturing company that designs and produces industrial machinery for the production of wooden packaging.
- EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
- Aviapartner Handling SpA — Aviapartner Handling is the European provider of airport ground handling services. Aviapartner Handling is the subsidiary of Aviapartner.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 194
- Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
- Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Angel group focuses on biotech
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 4
- Round size: Seed $549k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
3LB Seed Capital is not an alternative to start-ups incubators and accelerators, rather acts as a complementary reality that helps to enhance your project in terms of attractiveness for the investor and venture capital market.As investors they are the first willing to know if your project has what it takes to grow successfully. If they areconvinced of your potential, they are ready to bet on you, by joining you and helping you to develop your project.3LB Seed Capital does not provide a percentage of equity in exchange for accompanying activities, but relies exclusively on a premium at the time of its first direct investment in your company.
Show more...Investment focus
- Industry: E-Commerce, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 21
- Round size: Seed $71k–$2.5M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- YoAgents — Yo Agents nasce dalla unione delle competenze di ogni singolo founder messe a fattor comune per creare un sales hub innovativo.
- Botsociety — Your conversational design suite. Design and prototype your next chatbot or voice assistant. Create a mockup of your project on Messenger, Slack, Google Assistant, Alexa and more. The next generation design solution for chatbots and voice.
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 360
- Round size: Post-IPO Debt $18M–$658M; Debt Financing $16M–$384M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Affibody — Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a largenumber of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.
- RE:OCEAN — OUR MISSION IS TO FARM SALMON FOR THE BENEFIT OF HEALTH AND THE PLANET. WE'LL DO THIS BY BUILDING A LARGE SCALE FISH FARM IN THE middle OF SWEDEN. - WE'RE MAKING THE IMPOSSIBLE POSSIBLE - AN OCEAN ON LAND. RE:OCEAN IN BRIEF One in five salmons in Sweden 2026 will come from RE:OCEAN Fresh
- Metso Outotec —
Kering Ventures is the venture investment arm of the Kering Group, acquiring minority holdings in startups.
Show more...Investment focus
- Industry: Biotechnology, Interior Design
- Stage:Series A
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Series A $12M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MOGU — By employing one of its finest technologies, mycelium, Mogu delivers responsible products for interior design. Mycelium design with Mogu.
- SQIM — SQIM is a biotechnological based agency.
The Techshop is a venture capital and private equity firm that invests in B2B digital startups.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 23
- Round size: Seed $658k–$8.2M; Pre-Seed $658k–$38M; Series A $8.2M–$120M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- hlpy — hlpy operates as a roadside assistance company. Hlpy provides a digital roadside assistance service via a network of 580+ centers, 1,900+ drivers/mechanics, 2,800+ tow trucks.
- Smartness — Smartpricing is a provider of computer software application and revenue management system solutions to Hotel.
- Sustainable Brand Platform — Sustainable Brand Platform is the sustainability intelligence solution for fashion brands and manufacturers to accurately measure and manage their sustainability performance.
Enrico Pandian is the Co-Founder and CEO of StartupGym and the Founder of FrescoFrigo. He previously worked at Checkout Technologies as a Co-Founder and President of the Board. Enrico Pandian attended the University of Verona.
Show more...Investment focus
- Industry: E-Commerce, SaaS, FinTech
- Stage:Seed, Pre-Seed, Angel
- Geography: Italy, United States
Investor stats
- Total investments: 9
- Round size: Seed $2M–$3.3M; Pre-Seed $878k–$3.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mattermark — Mattermark lets you search for companies & investors to effortlessly create actionable lists for leads. Enrich your company data with customer intelligence from the industry leader of identity resolution.
- Everli — Scegli il supermercato, fai la spesa online e ricevila a casa all'ora che preferisci. Risparmia tempo ed evita code e borse pesanti con Everli.
- Viceversa — Viceversa provides capital to European digital businesses to support companies in sustainable and ethical growth. The company was founded in 2021 and has locations in Milan and Dublin.
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Italy, Sweden, Finland
Investor stats
- Total investments: 14
- Round size: Seed $553k–$2.9M; Pre-Seed $209k–$541k
- Lead/follow: 71% lead, 29% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
Longwood creates and invests in science-based companies that develop novel solutions for important medical problems
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Italy
Investor stats
- Total investments: 64
- Lead/follow: no public data
Portfolio highlights
- Pulmocide — Pulmocide is developing novel inhaled medicines for serious respiratory diseases
- Newleos Therapeutics — Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
DSM-Firmenich Venturing provides venture capital finance for startup firms.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Food and Beverage
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- one.bio — BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States.
- ExoLab Italia — Cosmetics Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations Supplements Plant-derived exosomes, rich in nutrients, enhance bioavailability by
- Enhanced Medical Nutrition — Enhanced Medical Nutrition builds clinical nutrition products to help patients prepare better and recover faster from surgery.
Planet A supports founders tackling the world's largest environmental problems. We're building the economy our planet needs.
Show more...Investment focus
- Industry: Software, Manufacturing, Renewable Energy
- Stage:Seed, Series A
- Geography: Germany, United Kingdom, Italy
Investor stats
- Total investments: 35
- Lead/follow: no public data
Portfolio highlights
- PULSETRAIN — Pulsetrain is the only company with a driving Multilevel demonstrator. Tech that moves, not just talks. AC Multilevel for construction machines. Ultra-high-power DC for next-gen vehicles. Game-changing. Let’s roll.
- Arsenale Bioyards — Arsenale is making industrial-scale biomanufacturing via precision fermentation economically viable for the very first time.
- C1 Green Chemicals — C1 develops climate friendly chemical production processes via computer simulation. Our first product is green methanol. Circular carbon chemistry reducing CO2.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Angels 4 Impact is a Business Angel investment firm that invests in startups with innovative and technological content and a focus on impact.
Show more...Investment focus
- Industry: Consulting, Biotechnology, Manufacturing
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.
- Envirly — Envirly is a Polish technology company that offers an innovative platform for managing sustainable development, and the carbon footprint of organizations and products.
- Vado — Vado is a technology startup that connects third-party delivery platforms and vending machines making order reception, management and delivery to the riders completely automatic.We are neither a delivery provider nor a vending machine manufacturer - we bridge the gap between them.In order to help companies manage the delivery and take-awayoperations of any product (Alcohol, Sushi, Drugs, Ready Foods) more efficiently, we integrate their delivery apps (Glovo, Deliveroo, JustEat, UberEats) with distributors automatic that allow you to sell automatically 24/7.Automating the online ordering process helps our customers save time and money, so they can focus more on their core business and continue doing what they love most: making their customers happy.
Lombardstreet Ventures operates as a pre-seed venture capital firm. It draws from talents around the world and fosters the creation of Silicon Valley Realities.The company consists of a team of seasoned executives works hand in hand with a small group of highly selected entrepreneurs. Expertise in funding and guidance is offered, to ensure thecreation of successful companies in the US.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Italy
Investor stats
- Total investments: 68
- Lead/follow: no public data
Portfolio highlights
- Atopile — Atopile develops tools for crafting electronic circuit board designs using code. By replacing the traditional point-and-click schematic interface with code, they bring software development methodologies such as reuse, validation, and automation into the realm of electronics.
- RetailReady — Streamline retail compliance with directed workflows that require no training or integrations, eliminating paper SOPs and spreadsheet tracking. RetailReady has solutions for all stakeholders - brands, retailers, and 3PLs with a unified, automated approach. Backed by Y Combinator.
- K-Scale Labs — K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots.
Launch Tennessee provides startup resources to entrepreneurs, including capital sources, mentorship, accelerators, entrepreneurship training and more
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Grant, Seed, Series A
- Geography: United States, China, Italy
Investor stats
- Total investments: 113
- Lead/follow: no public data
Portfolio highlights
- DAXOR — DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential totransform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
- Preteckt — Preteckt's AI software predicts & prevents breakdowns in buses & coaches. Reduce costs, maximize uptime, & extend vehicle life
- Daily Crunch — Daily Crunch is an offline and online store that offers cherry-berry nuts, cacao sea salt, and sprouted almonds products.
Entrepreneur and investor. After working in management consulting, in 2006 he created Wish Days, known above all for the Emozione3 gift boxes. In April 2016, he sold the company to the Smartbox group with a millionaire exit. In 2017, together with Cristina Pozzi, already a partner in Wish Days he founded Impactscool.He is advisor of dozens oftechnological initiatives and business angels in 150+ startups focusing on clean tech.He is the author of the book “Come far fallire una startup ed essere fellici” – How to make a startup fail and be happy, published by Bompiani, Bestseller in 2018.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Talyn Air — Inspired by two-stage rockets, our innovative eVTOL uses two flight vehicles to transform flight. Fixed-wing performance with VTOL capabilities.
- BillionToOne — We are a team at the forefront of disease detection focused on moving Prenatal Screening and Liquid Biopsy forward.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
Schia Ventures is investment firm.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Spindial Group
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Powering Breakthroughs in Life Sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 220
- Lead/follow: no public data
Portfolio highlights
- Firefly Bio — Firefly specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
- Umoja Biopharma — Pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells.
- Frontier Medicines — Frontier Medicines is boldly advancing science to defeat disease by pioneering innovations in precision-based medicines to target undruggable therapies
RECOMEC operates as a venture capital firm that primarily invests in the healthcare sector.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Pi Campus is a startup district and a venture fund that invests in talent. We provide startups with money, mentorship and the best work environment for growth.
Show more...Investment focus
- Industry: Software, Mobile, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 51
- Lead/follow: no public data
Portfolio highlights
- Loquis — La prima piattaforma per ascoltare e raccontare il mondo tramite podcast geolocalizzati
- Fondo — Fondo is an all-in-one accounting platform for startups. We'll handle your bookkeeping, tax, and tax credits so you can focus on building your startup.
- Intron Health — Intron is the future of clinical documentation with real-time clinical speech-to-text for 200+ African accents, easing the transition to digitized care.
Crédit Agricole Italia is a bank that offers loans and financial services.
Show more...Investment focus
- Industry: Financial Services, Finance, Water
- Stage:Debt Financing, Seed
- Geography: Italy
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- Ogyre —
- FoolFarm — UN NUOVO MODO DI CREARE STARTUP Investiamo in imprenditori con idee rivoluzionarie in AI e Deep-tech. Offriamo supporto operativo ed investimenti per costruire aziende leader attraverso un metodo validato ed un team esperto in startup. CANDIDA LA TUA IDEA DIVENT
- Krill Design — Krill Design is a design studio that creates circular economy projects to convert organic waste into material resources. It is a patented process that intercepts resources from the food supply chain to create zero-impact eco-designed 3D printed products.
Biotechnology Investor funding in Italy at a glance
Stats across 163 deals from 198 investors.
Access all 198 investors in Italy Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 198 investors investing in Italy Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!